Prostate Cancer - Results from #26980

Gonadotropin-releasing hormone blockers and cardiovascular disease risk: Analysis of prospective clinical trials of degarelix - Abstract October 20, 2011

The role of self-efficacy in quality of life for disadvantaged men with prostate cancer - Abstract October 20, 2011

Multiparametric 3T prostate magnetic resonance imaging to detect cancer: Histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds - Abstract October 20, 2011

Prostate cancer: Gleason scores correlation between biopsies and surgical gross specimen - Abstract October 20, 2011

Improved prediction of long-term, other cause mortality in men with prostate cancer - Abstract October 20, 2011

PC3 is a cell line characteristic of prostatic small cell carcinoma - Abstract October 20, 2011

A case of definitive therapy for localised prostate cancer: Report of a urological nightmare - Abstract October 19, 2011

Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancer - Abstract October 19, 2011

Enzymatic activity of free-prostate-specific antigen (f-PSA) is not required for some of its physiological activities - Abstract October 19, 2011

Inhibitory effect of dietary atorvastatin and celecoxib together with voluntary running wheel exercise on the progression of androgen-dependent LNCaP prostate tumors to androgen independence - Abstract October 19, 2011

Surveillance after prostate cancer radiotherapy - Abstract October 19, 2011

Clinical roundtable monograph: New and emerging treatments for advanced prostate cancer - Abstract October 19, 2011

Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases - Abstract October 19, 2011

Independent diagnostic and post-treatment prognostic models for prostate cancer demonstrate significant correlation with disease progression end points - Abstract October 19, 2011

Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy - Abstract October 18, 2011

Contrast-enhanced ultrasonography with contrast-tuned imaging technology for the detection of prostate cancer: Comparison with conventional ultrasonography - Abstract October 18, 2011

A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy - Abstract October 18, 2011

Dynamic gadolinium-enhanced perfusion MRI of prostate cancer: Assessment of response to hypofractionated robotic stereotactic body radiation therapy - Abstract October 18, 2011

External validation of the UCSF-CAPRA (University of California, San Francisco, Cancer of the Prostate Risk Assessment) in Japanese patients receiving radical prostatectomy - Abstract October 18, 2011

Adjuvant radiotherapy for a prostate cancer after renal transplantation and review of the literature - Abstract October 18, 2011

Page 1350 of 1438